A major cause of hospital-acquired infections, the super bacteria Methicillin-resistant Staphylococcus aureus (MRSA), not ...

SpliceBio's lead in-house pipeline project is in Stargardt disease, an IRD with no approved therapies that is caused by ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Panelists discuss how emerging intrathecal gene therapy for older patients with spinal muscular atrophy (SMA) shows modest ...

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...

Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

Spain’s SpliceBio will use $135 million from a series B round backed by Sanofi and Roche to advance its lead gene editing ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

A groundbreaking approach using mRNA-lipid nanoparticle technology has shown the ability to force HIV out of its latent state ...

Global Fulcrum™ license spans 20 countries for trait development in maize, wheat, sorghum, millets, pigeon pea, and groundnutDurham, N.C., and Texcoco, Mexico, June 12, 2025 (GLOBE NEWSWIRE) -- ...

A novel gene therapy for Alzheimer's disease, which showed promise to protect the brain from damage and preserve cognitive ...